BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9614072)

  • 1. 1alpha,25-dehydroxyvitamin D3 synergism toward transforming growth factor-beta1-induced AP-1 transcriptional activity in mouse osteoblastic cells via its nuclear receptor.
    Takeshita A; Imai K; Kato S; Kitano S; Hanazawa S
    J Biol Chem; 1998 Jun; 273(24):14738-44. PubMed ID: 9614072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements.
    Staal A; Van Wijnen AJ; Desai RK; Pols HA; Birkenhäger JC; Deluca HF; Denhardt DT; Stein JL; Van Leeuwen JP; Stein GS; Lian JB
    Endocrinology; 1996 May; 137(5):2001-11. PubMed ID: 8612541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An AP-1 site in the nerve growth factor promoter is essential for 1, 25-dihydroxyvitamin D3-mediated nerve growth factor expression in osteoblasts.
    Veenstra TD; Fahnestock M; Kumar R
    Biochemistry; 1998 Apr; 37(17):5988-94. PubMed ID: 9558335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1Alpha25(OH)2D3 interferes with retinoic acid-induced inhibition of c-fos gene expression for AP-1 formation in osteoblastic cells.
    Takeshita A; Yasuda H; Ishida M; Ochiai K
    J Oral Sci; 2002 Mar; 44(1):27-34. PubMed ID: 12058867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor beta-induced dissociation between vitamin D receptor level and 1,25-dihydroxyvitamin D3 action in osteoblast-like cells.
    Staal A; Birkenhäger JC; Pols HA; Buurman CJ; Vink-van Wijngaarden T; Kleinekoort WM; van den Bemd GJ; van Leeuwen JP
    Bone Miner; 1994 Jul; 26(1):27-42. PubMed ID: 7950503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element.
    Kuno H; Kurian SM; Hendy GN; White J; deLuca HF; Evans CO; Nanes MS
    Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mineralization of three-dimensional osteoblast cultures is enhanced by the interaction of 1α,25-dihydroxyvitamin D3 and BMP2 via two specific vitamin D receptors.
    Chen J; Dosier CR; Park JH; De S; Guldberg RE; Boyan BD; Schwartz Z
    J Tissue Eng Regen Med; 2016 Jan; 10(1):40-51. PubMed ID: 23784946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
    Kim S; Shevde NK; Pike JW
    J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-beta induces expression of monocyte chemoattractant JE/monocyte chemoattractant protein 1 via transcriptional factor AP-1 induced by protein kinase in osteoblastic cells.
    Takeshita A; Chen Y; Watanabe A; Kitano S; Hanazawa S
    J Immunol; 1995 Jul; 155(1):419-26. PubMed ID: 7602115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1 alpha,25-dihydroxyvitamin D3 increases TGF beta 1 binding to human osteoblasts.
    Nagel D; Kumar R
    Biochem Biophys Res Commun; 2002 Feb; 290(5):1558-63. PubMed ID: 11820800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes.
    Eelen G; Verlinden L; van Camp M; van Hummelen P; Marchal K; de Moor B; Mathieu C; Carmeliet G; Bouillon R; Verstuyf A
    J Bone Miner Res; 2004 Jan; 19(1):133-46. PubMed ID: 14753745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional regulation by transforming growth factor beta of the expression of retinoic acid and retinoid X receptor genes in osteoblastic cells is mediated through AP-1.
    Chen Y; Takeshita A; Ozaki K; Kitano S; Hanazawa S
    J Biol Chem; 1996 Dec; 271(49):31602-6. PubMed ID: 8940178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A two-hit mechanism for vitamin D3-mediated transcriptional repression of the granulocyte-macrophage colony-stimulating factor gene: vitamin D receptor competes for DNA binding with NFAT1 and stabilizes c-Jun.
    Towers TL; Staeva TP; Freedman LP
    Mol Cell Biol; 1999 Jun; 19(6):4191-9. PubMed ID: 10330159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional activity of a fluorinated vitamin D analog on VDR-RXR-mediated gene expression.
    Sasaki H; Harada H; Handa Y; Morino H; Suzawa M; Shimpo E; Katsumata T; Masuhiro Y; Matsuda K; Ebihara K
    Biochemistry; 1995 Jan; 34(1):370-7. PubMed ID: 7819220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1alpha-hydroxyvitamin D5.
    Mehta RG; Moriarty RM; Mehta RR; Penmasta R; Lazzaro G; Constantinou A; Guo L
    J Natl Cancer Inst; 1997 Feb; 89(3):212-8. PubMed ID: 9017001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective stimulation by ceramide of the expression of the alpha isoform of retinoic acid and retinoid X receptors in osteoblastic cells. A role of sphingosine 1-phosphate-mediated AP-1 in the ligand-dependent transcriptional activity of these receptors.
    Takeshita A; Watanabe A; Takada Y; Hanazawa S
    J Biol Chem; 2000 Oct; 275(41):32220-6. PubMed ID: 10915783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Singly dehydroxylated A-ring analogues of 19-nor-1alpha,25-dihydroxyvitamin D3 and 19-nor-22-oxa-1alpha,25-dihydroxyvitamin D3: novel vitamin D3 analogues with potent transcriptional activity but extremely low affinity for vitamin D receptor.
    Okano T; Nakagawa K; Tsugawa N; Ozono K; Kubodera N; Osawa A; Terada M; Mikami K
    Biol Pharm Bull; 1998 Dec; 21(12):1300-5. PubMed ID: 9881643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of 1 alpha,25-dihydroxyvitamin D3 response elements in the human transforming growth factor beta 2 gene.
    Wu Y; Craig TA; Lutz WH; Kumar R
    Biochemistry; 1999 Mar; 38(9):2654-60. PubMed ID: 10052935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interrelationship between signal transduction pathways and 1,25(OH)2D3 in UMR106 osteoblastic cells.
    Yang W; Hyllner SJ; Christakos S
    Am J Physiol Endocrinol Metab; 2001 Jul; 281(1):E162-70. PubMed ID: 11404234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonistic action of novel 1alpha,25-dihydroxyvitamin D3-26, 23-lactone analogs on differentiation of human leukemia cells (HL-60) induced by 1alpha,25-dihydroxyvitamin D3.
    Miura D; Manabe K; Ozono K; Saito M; Gao Q; Norman AW; Ishizuka S
    J Biol Chem; 1999 Jun; 274(23):16392-9. PubMed ID: 10347199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.